Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Main Capital and Björn Lundén in connection with the acquisition of Due Compliance AB
Mandate

Vinge has advised Main Capital and Björn Lundén in connection with the acquisition of Due Compliance AB

December 12, 2023 M&A Employment and Benefits Banking and Finance Data protection and processing of personal data Intellectual Property

Due Compliance is a software company which enables organisations to comply with the requirements in relation to Money Laundering and Terrorist Financing (Prevention) Act by providing digital tools for AML, KYC and Risk Assessments.

Björn Lundén, which is a strong provider of software for accounting, invoicing and payroll management, considers the acquisition of Due Compliance as an important step towards expanding its offering of digital tools in the regulatory market. The acquisition strengthens the group’s market position with the goal of becoming a leading player in Europe offering a comprehensive set of cloud-based accounting, ERP and RegTech solutions.
Vinge’s team consisted of Filip Öhrner, Josef Groow (M&A), Arvid Weimers, Karl-Gustaw Tobola, August Ahlin (Banking and Finance), Lisa Hörnqvist (IT and GDPR), Axel Lennartsson (IP), Victor Björkheim (employment) and Jessica Öijer (Transaction Support Senior Specialist).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025